KalVista Pharmaceuticals, Inc. (KALV) Operating Lease, Liability USD 2019 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
KalVista Pharmaceuticals, Inc. quarterly Operating Lease, Liability history and growth rate from 2019 to 2023.
  • KalVista Pharmaceuticals, Inc. Operating Lease, Liability for the quarter ending April 30, 2023 was $8.23 M, a 0.54% increase year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $8.23 M +$44 K +0.54% Apr 30, 2023 10-K 2023-07-10
Q1 2022 $8.19 M +$2.28 M +38.6% Apr 30, 2022 10-K 2022-07-07
Q2 2021 $7.38 M +$5.86 M +385% Jul 31, 2021 10-Q 2021-09-09
Q1 2021 $5.91 M +$4.26 M +259% Apr 30, 2021 10-K 2021-07-13
Q4 2020 $1.72 M +$197 K +13% Jan 31, 2021 10-Q 2021-03-11
Q3 2020 $1.35 M -$301 K -18.2% Oct 31, 2020 10-Q 2020-12-10
Q2 2020 $1.52 M -$234 K -13.3% Jul 31, 2020 10-Q 2020-09-14
Q1 2020 $1.65 M Apr 30, 2020 10-K 2020-07-01
Q4 2019 $1.52 M Jan 31, 2020 10-Q 2020-03-10
Q3 2019 $1.66 M Oct 31, 2019 10-Q 2019-12-03
Q2 2019 $1.76 M Jul 31, 2019 10-Q 2019-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.